XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity Compensation Plans
3 Months Ended
Mar. 31, 2024
Equity Compensation Plans [Abstract]  
EQUITY COMPENSATION PLANS

10. EQUITY COMPENSATION PLANS

 

In April 2018, the Company adopted the FlexShopper, Inc. 2018 Omnibus Equity Compensation Plan (the “2018 Plan”). The 2018 Plan replaced the Prior Plans. No new awards will be granted under the Prior Plans; however, awards outstanding under the Prior Plans upon approval of the 2018 Plan remain subject to and will be settled with shares under the applicable Prior Plan.

 

Grants under the 2018 Plan and the Prior Plans consist of incentive stock options, non-qualified stock options, stock appreciation rights, restricted shares, restricted stock units, dividend equivalents and other stock-based awards. Employees, directors and consultants and other service providers are eligible to participate in the 2018 Plan and the Prior Plans. As of March 31, 2024, approximately 2,150,461 shares remained available for issuance under the 2018 Plan.

 

Stock-based compensation expense include the following components:

  

   Three Months Ended
March 31,
 
   2024   2023 
Stock options  $80,444   $420,748 
Performance share units (“PSU”)   136,681    
-
 
Total stock-based compensation  $217,125   $420,748 

 

The fair value of stock-based compensation is recognized as compensation expense over the vesting period. Compensation expense recorded for stock-based compensation in the condensed consolidated statements of operations was $217,125 for the three months ended March 31, 2024 and $420,748 for three months ended March 31, 2023. Unrecognized compensation cost related to non-vested options and PSU at March 31, 2024 amounted to $964,416, which is expected to be recognized over a weighted average period of 2.01 years.

 

Stock options:

 

The fair value of stock options is recognized as compensation expense using the straight-line method over the vesting period. The Company measured the fair value of each stock option award on the date of grant using the Black-Scholes-Merton (BSM) pricing model. The Company didn’t grant stock options during the three months periods ending March 31, 2024 and March 31, 2023.

 

Activity in stock options for the three months period ended March 31, 2024 and March 31, 2023 was as follows:

 

   Number of
options
   Weighted
average
exercise
price
   Weighted
average
contractual
term
(years)
   Aggregate
intrinsic
value
 
Outstanding at January 1, 2024   4,452,447   $1.57        $2,152,602 
Expired   (55,000)   8.00         
-
 
Outstanding at March 31, 2024   4,397,447   $1.49    7.18   $1,630,800 
Vested and exercisable at March 31, 2024   3,661,778   $1.56    6.96   $1,257,638 
                     
Outstanding at January 1, 2023   3,919,228   $1.97        $52,223 
Exercised   (1,500)   0.79         345 
Outstanding at March 31, 2023   3,917,728   $1.97    6.54   $3,016 
Vested and exercisable at March 31, 2023   3,555,094   $1.98    6.47   $3,016 

 

Performance Share Units:

 

On February 10, 2022, and on April 21, 2023, the Compensation Committee of the Board of Directors approved awards of performance share units to certain senior executives of the Company.

 

For performance share units, which are settled in stock, the number of shares earned is subject to both performance and time-based vesting. For the performance component, the number of shares earned is determined at the end of the periods based upon achievement of specified performance conditions such as the Company’s Adjusted EBITDA. When the performance criteria are met, the award is earned and vests assuming continued employment through the specified service period(s). Shares are issued from the Company’s 2018 Omnibus Equity Compensation Plan upon vesting. The number of 2023 PSU which could potentially be issued ranges from 0 up to a maximum of 1,250,000 of the target awards depending on the specified terms and conditions of the target award.

 

The fair value of performance share units is based on the fair market value of the Company’s common stock on the date of grant. The compensation expense associated with these awards is amortized on an accelerated basis over the vesting period based on the Company’s projected assessment of the level of performance that will be achieved and earned. In the event the Company determines it is no longer probable that the minimum performance criteria specified in the plan will be achieved, all previously recognized compensation expense is reversed in the period such a determination is made. The 2022 PSU were forfeited in April 2023 as the minimum performance component was not achieved. For the 2023 PSU, the Company determined it was probable that the minimum performance component would be met and accordingly commenced amortization in the quarter ended June 30, 2023. 

 

Activity in performance share units for the three months period ended March 31, 2024 was as follows:

 

   Number of
performance
share units
   Weighted
average
grant date
fair value
 
Non- vested at January 1, 2024   1,250,000   $0.78 
Granted   
-
    
-
 
Forfeited/ unearned   
-
    
-
 
Vested   
-
    
-
 
Non- vested at March 31, 2024   1,250,000   $0.78 
           
Non- vested at January 1, 2023   790,327   $1.53 
Granted   
-
    
-
 
Forfeited/ unearned   
-
    
-
 
Vested   
-
    
-
 
Non- vested at March 31, 2023   790,327   $1.53